Construction has started in earnest on a major vaccine manufacturing plant in Ethiopia, which Health Minister, Lia Tadesse says will significant improve the supply of vaccines across the region.
The vaccine manufacturing company, with an investment of over 70 million U.S. dollars, is being built inside the premises of Ethiopia’s Chinese-built Kilinto Industrial Park on the outskirts of the capital, Addis Ababa, the state-affiliated Fana Broadcasting Corporate reported.
ShieldVax Enterprise Project as it is being called was established by the Council of Ministers in July 2023 with a view to building a strong health system in Ethiopia.
After the Covid-19 pandemic, developing local vaccine manufacturing capacity become one of Ethiopia’s top priorities.
Ethiopia’s Chinese-built Kilinto Industrial Park, constructed by Tiesiju Civil Engineering Group Co., Ltd. at a cost of 204 million dollars and specializing in the pharmaceutical sector, is one of the 12 industrial parks and one free trade zone across the country.
Also Read
Lobito Corridor given top priority in AfDB, EU infrastructure deal
Mining firm Glencore deepens sustainability with new 25MV solar PV plant
- SODECA Highlights Industrial Ventilation Technology at Mega Clima Expo Kenya 2026 - October 14, 2026
- How They Were Built: Inside the Engineering of the Lesotho Highlands Water Project - October 11, 2026
- Africa’s Water Reuse Opportunity: Building the Infrastructure for a Water-Secure Future - September 28, 2026
